Ramiven Abemaciclib
Price range: $445 through $1,265Ramiven Abemaciclib is a powerful oral CDK4/6 inhibitor used alongside endocrine therapy for hormone receptor-positive (HR+), HER2-negative breast cancers—both advanced/metastatic and high-risk early-stage. It blocks cancer cell division, helping delay disease progression under oncologist supervision.